Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The value of vasodilator therapy in acute and chronic heart failure is well established. Vasodilators improve symptoms and prognosis in patients with severe clinical symptoms refractory to the treatment with diuretics and digitalis. Angiotensin-converting enzyme (ACE) inhibitors were beneficial even in less severe heart failure. Most recent studies suggest that prevention of heart failure is possible in patients with severe left ventricular dysfunction.


Journal article


Herz Kreislauf

Publication Date





358 - 360